204 related articles for article (PubMed ID: 27351920)
1. Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).
Li J; Smith A; Crouch S; Oliver S; Roman E
Cancer Causes Control; 2016 Aug; 27(8):1019-26. PubMed ID: 27351920
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
6. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
Lamb M; Painter D; Howell D; Barrans S; Cargo C; de Tute R; Tooze R; Burton C; Patmore R; Roman E; Smith A
Cancer Epidemiol; 2024 Feb; 88():102513. PubMed ID: 38160571
[TBL] [Abstract][Full Text] [Related]
8. The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.
Dandoit M; Mounier M; Guy J; Petrella T; Girard S; Casasnovas RO; Martin L; Bonnetain F; Maynadié M
Leuk Lymphoma; 2015 Apr; 56(4):1050-7. PubMed ID: 25166007
[TBL] [Abstract][Full Text] [Related]
9. Haematological malignancies in a general population, based on information collected from a population study, hospital records, and the Cancer Registry of Norway: the Tromsø Study.
Skjelbakken T; Løchen ML; Dahl IM
Eur J Haematol; 2002 Aug; 69(2):67-75. PubMed ID: 12366709
[TBL] [Abstract][Full Text] [Related]
10. Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004-2013.
Oelofse D; Truter I
Cancer Epidemiol; 2018 Apr; 53():166-171. PubMed ID: 29462765
[TBL] [Abstract][Full Text] [Related]
11. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.
Smith A; Roman E; Howell D; Jones R; Patmore R; Jack A;
Br J Haematol; 2010 Mar; 148(5):739-53. PubMed ID: 19958356
[TBL] [Abstract][Full Text] [Related]
12. Patterns of hematological and non-hematological malignancies in bone marrow in a tertiary care hospital in Nepal--11 years study.
Ghartimagar D; Ghosh A; Narasimhan R; Talwar OP
Nepal Med Coll J; 2012 Sep; 14(3):187-92. PubMed ID: 24047012
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
14. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
15. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.
Roman E; Smith A; Appleton S; Crouch S; Kelly R; Kinsey S; Cargo C; Patmore R
Cancer Epidemiol; 2016 Jun; 42():186-98. PubMed ID: 27090942
[TBL] [Abstract][Full Text] [Related]
16. Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
Jayasekara H; Karahalios A; Juneja S; Thursfield V; Farrugia H; English DR; Giles GG
Leuk Lymphoma; 2010 Mar; 51(3):456-68. PubMed ID: 20141433
[TBL] [Abstract][Full Text] [Related]
17. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.
Smith A; Howell D; Patmore R; Jack A; Roman E
Br J Cancer; 2011 Nov; 105(11):1684-92. PubMed ID: 22045184
[TBL] [Abstract][Full Text] [Related]
18. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
Monnereau A; Troussard X; Belot A; Guizard AV; Woronoff AS; Bara S; Lapôtre-Ledoux B; Iwaz J; Tretarre B; Maynadié M;
Int J Cancer; 2013 May; 132(10):2378-87. PubMed ID: 23034773
[TBL] [Abstract][Full Text] [Related]
19. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
20. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
